The end of the Healthy Opportunities Pilot in North Carolina is a story of how MAHA might actually be realized — or not — at ...

The end of the Healthy Opportunities Pilot in North Carolina is a story about how MAHA might be realized — or not — at the ...

While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

For 60 years, HSL was known for releasing energy from fat, but people born without it lose fat instead of gaining weight—a mystery that Prof. Langin and colleagues have now solved. After six decades ...

The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million ...

India had the second-highest number of people with chronic kidney disease in 2023 at 138 million, following China at 152 million, according to a global study published in The Lancet journal.

The condition, which causes the kidneys to gradually stop working, is already thought to contribute to 45,000 deaths in the ...

The Food Research & Action Center calls SNAP item bans misguided, arguing the better path is incentives and access rather ...

Expect to hear President Donald Trump talk a lot about affordability in coming months. The White House is adjusting its ...

Obesity drugs like Ozempic and Wegovy are seen as major breakthroughs for those with chronic diseases like obesity and ...

Amylin is a peptide co-secreted with insulin in response to food intake. It controls gastric emptying, inhibits glucagon secretion, and promotes satiety. Several amylin receptor agonists are in ...